Your Brain, Your Clock, Your Habits — Three Studies Worth Knowing

Episode Script

Thanks Toni. We've got a good one today.

Three papers, all dropped at the end of July, all sitting in my queue since then. Today felt like the right day to dig in — because two of them are touching territory that generates a lot of noise online, and I want to give you the actual signal.

Let's start with the one that's been making the rounds in a few menopause forums: the question of whether hormone therapy can reduce a woman's risk of Alzheimer's disease.

The paper is a narrative review, published July 31st by Wang and colleagues. Before we get into what it found, it's worth knowing what a narrative review actually is — because it matters for how much weight you give the conclusions. A narrative review is essentially a researcher reading through a large pile of existing studies and summarizing the patterns they see. It's not a meta-analysis, which pools raw data from many studies and runs statistics on all of it. A narrative review is more like a very well-informed survey of the landscape. Useful. Not definitive.

With that said — the landscape it's surveying is genuinely interesting.

The review looks at the relationship between estrogen loss at menopause and the risk of developing Alzheimer's disease later in life. And there is a real biological story here. Estrogen plays a role in how brain cells use energy, in inflammation, and in the health of the connections between neurons. When estrogen drops sharply at menopause, some of that protection goes with it. Women develop Alzheimer's at higher rates than men, and the gap isn't fully explained by the fact that women live longer — there's something specific happening around the hormonal transition.

So the question the review asks is: does giving estrogen back — through hormone therapy — lower that risk?

The answer the evidence gives right now is: maybe, and timing appears to be a lot of it.

Studies that follow women who started hormone therapy early — meaning during perimenopause or within a few years of their last period — tend to show lower rates of cognitive decline and dementia. Studies that started women on therapy much later, well after menopause, sometimes show the opposite — a slight increase in risk in older women. This is what researchers call the critical window hypothesis. The idea is that there's a window early in the hormonal transition when estrogen therapy may protect the brain, and if you wait too long, the brain's estrogen receptors have already changed in ways that make the intervention less helpful, or potentially harmful.

This is not a new idea — the critical window has been discussed for over a decade. But the review suggests the evidence for it is getting stronger, not weaker.

My take: this is worth knowing about, and worth bringing up with your doctor if you're thinking about hormone therapy. It is not, however, a proven benefit the way, say, HRT's effect on hot flashes is proven. The studies here are largely observational — meaning researchers looked at women who happened to be on HRT versus women who weren't, rather than randomly assigning them. Women who seek out and stay on hormone therapy may differ in other ways — they may be higher income, more likely to exercise, more likely to have regular medical care — and those differences are hard to fully account for. The kind of evidence your doctor would look at on a tool like OpenEvidence would flag those limitations quickly. So: promising, worth discussing, not yet settled.

The second paper this week touches something adjacent: epigenetic aging.

This one, from Wei and colleagues, asks whether hormone therapy affects what's called the epigenetic clock — which is a way of measuring biological age rather than calendar age. Here's what that means in plain terms. Your DNA doesn't just carry your genes. It also carries chemical tags that control whether genes get switched on or off. As you age, those tags change in predictable patterns. Scientists have built tools that look at those patterns and estimate how old your cells are acting, separate from how many birthdays you've had. That estimate is your epigenetic age.

Sometimes your epigenetic age and your actual age match. Sometimes they don't. If your biological age runs older than your calendar age, that tends to correlate with higher risk for a range of diseases. If it runs younger, that's generally a good sign.

What the Wei paper looks at is whether estrogen — either the body's own or through hormone therapy — relates to epigenetic aging. The short version of what they found: estrogen signaling appears associated with a slower biological clock, and that relationship seems to be stronger in women with stable, healthy blood sugar levels. Women with higher blood sugar — prediabetes range and above — seemed to get less of that apparent benefit.

I want to be careful here, because this paper is looking at mechanisms and associations, not outcomes. It's not saying "take estrogen and you'll live longer." It's pointing at a biological pathway that might be part of why estrogen loss at menopause accelerates certain aging processes. The blood sugar angle is worth flagging, though, because it shows up across a lot of menopause research — the hormonal shift at perimenopause makes blood sugar harder to regulate, and that dysregulation seems to compound other risks. Keeping blood sugar stable through diet, through strength training, through sleep — all of it may matter more in these years than it did in your thirties.

The third paper is a different kind of study entirely, and honestly I find it useful in a practical way the other two aren't.

This one is from Fu and colleagues, also published July 31st. They looked at health-promoting behaviors in perimenopausal women using something called the COM-B model, which is a framework from behavioral science that breaks down why people do or don't engage in healthy behaviors. COM stands for Capability, Opportunity, Motivation — the idea being that behavior change requires all three, and if any one is missing, the behavior doesn't stick.

What they did is a latent profile analysis — which is a statistical method for finding natural clusters in a population. Instead of asking "what does the average perimenopausal woman do for her health," they asked "are there distinct types of perimenopausal women based on their health behaviors, and if so, what does each type look like?"

They found three profiles. One group scored high across the board — physical activity, nutrition, stress management, sleep habits, the works. A second group was doing reasonably well on some things, particularly nutrition and medical checkups, but lagging significantly on physical activity and stress management. The third group had gaps across multiple areas, with the most pronounced deficits in physical activity and emotional regulation.

The majority of women in the study did not fall into the high-performing group. Most landed in one of the other two.

What I think is actually useful about this framing: it pushes back against the way we usually talk about lifestyle advice in menopause. We tend to present it as a uniform list — exercise more, eat better, sleep more, stress less — as if all women are starting from the same place. This research says they're not. A woman who's already eating well but completely sedentary needs a different conversation than a woman who walks every day but is emotionally exhausted and running on four hours of sleep. The intervention that would actually help her is different.

That's a small but real shift in how to think about this. Not "here is the list of things you should be doing," but "which part of the list is your actual gap, and why." The COM-B lens says: if you're not doing something, it's either because you don't know how, or the circumstances of your life don't make it easy, or you don't feel pulled toward it. Those are three different problems with three different solutions.

If you're perimenopausal and you've been frustrated that the lifestyle advice doesn't seem to stick — it may be worth asking which of those three it is for you. Because "try harder" only works when motivation is the gap. If it's capability or opportunity, trying harder just adds guilt to an already difficult situation.

TITLE: Your Brain, Your Clock, Your Habits — Three Studies Worth Knowing DESCRIPTION: HRT and Alzheimer's risk, epigenetic aging, and why most perimenopausal women's health habits cluster in predictable (and fixable) ways.

---

Sources curated automatically by the Hot Flasher pipeline.